3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Endometrial Neoplasms
2
Breast Neoplasms
2
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Overweight
1
Obesity
1
Motor Activity
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Infertility
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Cognitive Dysfunction
1
Interventions
pembrolizumab
27
Cisplatin
18
Cetuximab
12
Carboplatin
12
Surveys and Questionnaires
8
Radiotherapy
8
Paclitaxel
8
Docetaxel
6
Radiotherapy, Intensity-Modulated
5
Surgical Procedures, Operative
4
dostarlimab
3
Therapeutics
3
Standard of Care
3
Fluorouracil
3
Cyclophosphamide
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
nimotuzumab
2
fludarabine
2
durvalumab
2
atezolizumab
2
abemaciclib
2
X-Rays
2
Taxes
2
Radiosurgery
2
Radiation
2
Nivolumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Tablets
×
90 days
×
Clear all
No trials found.